Roche (RHHBY) Demonstrates Strong Commitment to Neurodevelopmental Disorders
Tuesday, June 18, 2013
More...
|
Roche (RHHBY)'s Avastin Approved in Japan for Treatment of Aggressive Brain Cancer
Tuesday, June 18, 2013
More...
|
Novartis AG (NVS) Sacks 18 for Fabricating Sales Data
Monday, June 17, 2013
More...
|
Celgene International Sárl (CELG) Oral Anti-Cancer Therapy REVLIMID® (lenalidomide) Now Indicated as a Treatment for Patients With Rare Form of Blood Disease
Monday, June 17, 2013
More...
|
Gilead Sciences, Inc. (GILD) Announces Interim Phase 2 Data for Idelalisib Showing Response in Refractory Indolent Non-Hodgkin's Lymphoma
Monday, June 17, 2013
More...
|
Genmab A/S (GEN.CO) and ADC Therapeutics Enter Co-Development Collaboration for an Antibody-Drug Conjugate Combining HuMax-TAC and PBD Warhead
Monday, June 17, 2013
More...
|
Celgene International Sárl (CELG)'s Apremilast Improves Oral Ulcer Pain From Behcet's Disease
Friday, June 14, 2013
More...
|
Unilabs SA and Natera Initiate Partnership for Distribution of Non-Invasive Prenatal Test, Panorama™, in Switzerland/Scandinavia
Thursday, June 13, 2013
More...
|
Anergis Files Provisional U.S. Patent on AllerDM Dust Mite Allergy Treatment
Thursday, June 13, 2013
More...
|
Celgene International Sárl (CELG) Release: Data From Phase III Randomized Controlled Study (Palace 3) of Apremilast in Psoriatic Arthritis Presented at EULAR
Thursday, June 13, 2013
More...
|
|